Tumour Marker Blood Testing

Blood-based cancer biomarker panel for surveillance and monitoring

Tumour marker blood testing measures specific proteins and substances elevated by certain cancers — including PSA (prostate), CA-125 (ovary), CEA (colorectal), AFP (liver), CA 19-9 (pancreas) and CA 15-3 (breast). Used in screening, diagnosis and treatment monitoring, they provide valuable information when interpreted alongside clinical findings.

A standalone tumour marker panel can be arranged for patients wanting a comprehensive blood-based cancer overview, or as a component of a full-body cancer check-up.

Key Benefits

Multiple cancer markers assessed from a single blood draw
Useful for surveillance in patients with a previous cancer history
Aids in monitoring response to cancer treatment
Physician-interpreted results in clinical context

Is This Treatment Right For You?

Patients with a personal cancer history wanting ongoing surveillance
Those with strong family history wanting baseline marker levels
Anyone undergoing cancer treatment monitoring

What to Expect

Panel Selection

Relevant markers selected based on clinical history and risk profile.

Blood Draw

Single blood sample taken for full marker panel.

Laboratory Analysis

Markers measured in a certified laboratory.

Results Consultation

Physician interprets results in clinical context and advises on any follow-up.

Recovery & Aftercare

No downtime — blood draw only.

Frequently Asked Questions

Are tumour markers accurate for cancer diagnosis?

Tumour markers are supportive tools, not diagnostic tests on their own; they are most valuable for monitoring known cancer or as part of a broader screening assessment — elevated markers require follow-up investigation.

Which tumour marker tests should I get?

This depends on your age, sex, symptoms and family history; your physician will recommend the relevant panel for your profile.